Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haim

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
American Health & Drug Benefits|August 16, 2014
Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopramEric Q Wu, Paul E Greenberg, Rym Ben-Hamadi, et al.
Digestive Diseases and Sciences|January 25, 2017
PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux DiseaseGarth Fuller, Roger Bolus, Cynthia Whitman, et al.
Microbiology (Reading, England)|September 7, 2010
Cytokeratin 8 interacts with clumping factor B: a new possible virulence factor targetM Haim, A Trost, C J Maier, et al.
Pharmacoepidemiology and Drug Safety|September 27, 2014
Development and validation of algorithms to identify acute diverticulitisAniket Kawatkar, Li-Hao Chu, Rajan Iyer, et al.
Journal of Child and Adolescent Psychopharmacology|May 21, 2014
Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009Keith A Betts, Vanja Sikirica, Paul Hodgkins, et al.
American Heart Journal|August 15, 1998
Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine TrialM Haim, S Gottlieb, V Boyko, et al.
Current Medical Research and Opinion|March 7, 2014
Prevalence and incidence of adult attention deficit/hyperactivity disorder in a large managed care populationTara K Knight, Aniket Kawatkar, Paul Hodgkins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 2, 2012
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJalpa A Doshi, Paul Hodgkins, Jennifer Kahle, et al.
The Patient|October 26, 2014
Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative researchVanja Sikirica, Emuella Flood, C Noelle Dietrich, et al.
European Child & Adolescent Psychiatry|October 30, 2013
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference caseHoa H Le, Paul Hodgkins, Maarten J Postma, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
American Health & Drug Benefits|August 16, 2014
Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopramEric Q Wu, Paul E Greenberg, Rym Ben-Hamadi, et al.
Digestive Diseases and Sciences|January 25, 2017
PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux DiseaseGarth Fuller, Roger Bolus, Cynthia Whitman, et al.
Microbiology (Reading, England)|September 7, 2010
Cytokeratin 8 interacts with clumping factor B: a new possible virulence factor targetM Haim, A Trost, C J Maier, et al.
Pharmacoepidemiology and Drug Safety|September 27, 2014
Development and validation of algorithms to identify acute diverticulitisAniket Kawatkar, Li-Hao Chu, Rajan Iyer, et al.
Journal of Child and Adolescent Psychopharmacology|May 21, 2014
Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009Keith A Betts, Vanja Sikirica, Paul Hodgkins, et al.
American Heart Journal|August 15, 1998
Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine TrialM Haim, S Gottlieb, V Boyko, et al.
Current Medical Research and Opinion|March 7, 2014
Prevalence and incidence of adult attention deficit/hyperactivity disorder in a large managed care populationTara K Knight, Aniket Kawatkar, Paul Hodgkins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 2, 2012
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJalpa A Doshi, Paul Hodgkins, Jennifer Kahle, et al.
The Patient|October 26, 2014
Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative researchVanja Sikirica, Emuella Flood, C Noelle Dietrich, et al.
European Child & Adolescent Psychiatry|October 30, 2013
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference caseHoa H Le, Paul Hodgkins, Maarten J Postma, et al.
Pageof 12